The immunisation programme in Ireland is based on the advice of the National Immunisation Advisory Committee (NIAC). The committee's recommendations are based on the prevalence of the relevant disease in Ireland and international best practice in relation to immunisation.
The ages at which vaccines are recommended in the immunisation schedule are chosen by the NIAC in order to give each child the best possible protection against vaccine preventable diseases. As the HPV vaccine is preventative it is intended to be administered, if possible, before a person becomes sexually active, that is, before a person is first exposed to HPV infection.
Therefore, the gender-neutral HPV vaccination programme targets all girls and boys in first year of secondary school to provide maximum coverage.
In October 2021, my Department asked the National Immunisation Advisory Committee to consider the clinical effectiveness of providing the HPV vaccine to:
- girls and boys in secondary school who were eligible to receive HPV vaccine in 1st year but who did not receive it; and
- women up to the age of 25 years who have left secondary school and who did not receive the vaccine when eligible.
I can confirm that the NIAC recently submitted its advices in relation to the HPV Vaccination Programme to my Department. As part of its advices, the NIAC noted that HPV vaccination should be prioritised for unvaccinated second level students and females under the age of 25 years.
In line with that advice, I have asked the HSE to provide an opportunity for all boys and girls in secondary schools who were previously eligible to receive the HPV vaccine and who have not yet, for whatever reason, received it, to now be offered the vaccine.
My Department will continue to be guided by NIAC's recommendations on any emerging evidence on this issue in the future.
